Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IDEAYA Biosciences (IDYA) EPS (Basic) (2020 - 2025)

Historic EPS (Basic) for IDEAYA Biosciences (IDYA) over the last 6 years, with Q3 2025 value amounting to $1.35.

  • IDEAYA Biosciences' EPS (Basic) rose 27394.12% to $1.35 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.48, marking a year-over-year increase of 4324.51%. This contributed to the annual value of -$3.36 for FY2024, which is 7142.86% down from last year.
  • As of Q3 2025, IDEAYA Biosciences' EPS (Basic) stood at $1.35, which was up 27394.12% from -$1.55 recorded in Q4 2024.
  • IDEAYA Biosciences' EPS (Basic)'s 5-year high stood at $1.35 during Q3 2025, with a 5-year trough of -$1.55 in Q4 2024.
  • Its 5-year average for EPS (Basic) is -$0.43, with a median of -$0.49 in 2023.
  • Per our database at Business Quant, IDEAYA Biosciences' EPS (Basic) tumbled by 125000.0% in 2023 and then surged by 27394.12% in 2025.
  • IDEAYA Biosciences' EPS (Basic) (Quarter) stood at -$0.49 in 2021, then fell by 10.2% to -$0.54 in 2022, then increased by 3.7% to -$0.52 in 2023, then plummeted by 198.08% to -$1.55 in 2024, then skyrocketed by 187.1% to $1.35 in 2025.
  • Its EPS (Basic) was $1.35 in Q3 2025, compared to -$1.55 in Q4 2024 and -$0.78 in Q3 2024.